• Home
  • Study Details
By physician referral or invitation only

PREVENT-COVID: A Study for IBD Patients who have received or plan to receive the COVID-19 Vaccine

The purpose of this study is to learn more about how well the COVID-19 vaccine works for patients with IBD. This includes people with Crohn's disease and ulcerative colitis. We want to learn more about side effects and whether the vaccine impacts IBD activity. This study does not provide the COVID-19 vaccine and is only for people who have already received at least 1 vaccine.

Age & Gender

  • 5 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team


Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Kimberly Weaver

Study Type

Clinical or Medical

Study Topics

Chronic Conditions
Stomach, Digestion and Gut Health
Immune System/Infections

IRB Number


logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.


  • This email address is being protected from spambots. You need JavaScript enabled to view it.